Personal Genome Diagnostics (PGDx), founded by leading researchers from Johns Hopkins University, provides advanced cancer genome analysis to help researchers and partners identify elusive cancer-related genetic changes.
PGDx offers a suite of cancer genome analyses services to identify alterations in any tumor of interest. Our services sensitively and specifically identify genomic variants which can be linked to the underlying biology of cancer.
PGDx also establishes co-development partnerships with industry to create companion diagnostic products for the personalized medicines of the future.
©2019 Personal Genome Diagnostics, Inc. All Rights Reserved.
